312 related articles for article (PubMed ID: 24525912)
1. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome.
Risselada AP; Kruize AA; Goldschmeding R; Lafeber FP; Bijlsma JW; van Roon JA
Ann Rheum Dis; 2014 Aug; 73(8):1537-40. PubMed ID: 24525912
[TBL] [Abstract][Full Text] [Related]
2. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
[TBL] [Abstract][Full Text] [Related]
3. Labial salivary gland biopsy in Sjögren's syndrome.
Bodeutsch C; de Wilde PC; Kater L; Hené RJ; van den Hoogen FH; van de Putte LB; Vooijs GP
Neth J Med; 1992 Apr; 40(3-4):148-57. PubMed ID: 1603205
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell populations in labial salivary glands from patients with and without Sjögren's syndrome.
Matthews JB; Deacon EM; Wilson C; Potts AJ; Hamburger J
Histopathology; 1993 Nov; 23(5):399-407. PubMed ID: 8314212
[TBL] [Abstract][Full Text] [Related]
5. The synergistic value of focus score and IgA% score of sublabial salivary gland biopsy for the accuracy of the diagnosis of Sjögren's syndrome: a 10-year comparison.
Zandbelt MM; Wentink JR; de Wilde PC; van Damme PA; van de Putte LB; van den Hoogen FH
Rheumatology (Oxford); 2002 Jul; 41(7):819-23. PubMed ID: 12096234
[TBL] [Abstract][Full Text] [Related]
6. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome.
Bodeutsch C; de Wilde PC; Kater L; van Houwelingen JC; van den Hoogen FH; Kruize AA; Hené RJ; van de Putte LB; Vooijs GP
Arthritis Rheum; 1992 Sep; 35(9):1075-87. PubMed ID: 1418024
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
9. Minor salivary gland fibrosis in Sjögren's syndrome is elevated, associated with focus score and not solely a consequence of aging.
Leehan KM; Pezant NP; Rasmussen A; Grundahl K; Moore JS; Radfar L; Lewis DM; Stone DU; Lessard CJ; Rhodus NL; Segal BM; Scofield RH; Sivils KL; Montgomery C; Farris AD
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):80-88. PubMed ID: 29148407
[TBL] [Abstract][Full Text] [Related]
10. Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren's syndrome.
Speight PM; Cruchley A; Williams DM
J Oral Pathol Med; 1990 Mar; 19(3):126-30. PubMed ID: 2187976
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome: histologic and immunohistochemical study.
Huguet P; Bosch JA; Raventós A; Jacas C; Sanjosé A; Vilardell M
Ann Med Interne (Paris); 1995; 146(4):233-4. PubMed ID: 7653941
[TBL] [Abstract][Full Text] [Related]
12. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
13. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
14. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study.
Zandbelt MM; de Wilde P; van Damme P; Hoyng CB; van de Putte L; van den Hoogen F
J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226
[TBL] [Abstract][Full Text] [Related]
15. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.
Christodoulou MI; Kapsogeorgou EK; Moutsopoulos NM; Moutsopoulos HM
Am J Pathol; 2008 Nov; 173(5):1389-96. PubMed ID: 18818377
[TBL] [Abstract][Full Text] [Related]
17. Lymphocytic focus score as a prognostic tool.
Risselada AP; Hair Md; Kruize AA; Bijlsma JW; van Roon JA
Ann Rheum Dis; 2015 Apr; 74(4):e31. PubMed ID: 25589514
[No Abstract] [Full Text] [Related]
18. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndrome.
Bodeutsch C; de Wilde PC; Kater L; van den Hoogen FH; de Jong AJ; Borstlap WA; van de Putte LB; Vooijs GP
Neth J Med; 1991 Apr; 38(3-4):110-6. PubMed ID: 1881496
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.
Theander E; Vasaitis L; Baecklund E; Nordmark G; Warfvinge G; Liedholm R; Brokstad K; Jonsson R; Jonsson MV
Ann Rheum Dis; 2011 Aug; 70(8):1363-8. PubMed ID: 21715359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
